ECGC withdraws coverage for shipments to Russia; huge setback for exporters, says FIEO
The Hindu
The Export Credit Guarantee Corporation (ECGC) has decided to withdraw coverage for shipments to Russia with effect from February 25, which is a huge setback for exporters, industry body FIEO said on Saturday.
Amid the ongoing conflict between Russia and Ukraine, ECGC in a communication said "based on the near-term commercial outlook, it has been decided to modify the country-risk classification of Russia under the short-term and medium and long term with effect from February 25." Revising its underwriting policy on Russia, ECGC, a government-owned entity, has now put that country in the Restricted Cover Category (RCC-I) from the earlier 'open cover' category.
Open cover categories enable policyholders to obtain cover on a more liberalised basis.
Federation of Indian Export Organisations (FIEO) Director General Ajay Sahai said that ECGC has "suddenly" withdrawn the coverage to shipments for Russia with effect from February 25.
"Such action is a huge setback to the exporting fraternity as the fate of cargoes which are at various Indian ports, some after customs clearance, for shipments will not be covered as ECGC has mandated Bill of Lading cut off date till February 25.
"Secondly, policies in force hold no good as risks are withdrawn. This immediate act of ECGC is a setback for exporters as political risks are one of the major components which ECGC covers," Mr. Sahai said.
ECGC Ltd., wholly owned by the Government of India, was set up in 1957 with the objective of promoting exports from the country by providing credit risk insurance and related services.
Stock markets decline after two days of gains, with subdued trading expected amid a holiday-shortened week.
Rupee dips to 89.73 against the dollar as Sensex and Nifty also decline amid FII outflows and weak market conditions.
Mercedes-Benz settles multistate emissions allegations for $149.6 million, addressing illegal devices in over 211,000 vehicles.
U.S. approves Wegovy pill for weight loss, expanding access to obesity treatment with a convenient daily oral option.
RBI Bulletin highlights resilient economic activity in India, driven by robust demand, despite challenges in external trade and inflation.
Biofabri and Bharat Biotech partner to advance MTBVAC, a tuberculosis vaccine, ensuring equitable access and manufacturing readiness in India.
India anticipates doubling trade with New Zealand to $5 billion in five years following a historic women-led free trade agreement.
Rupee dips 3 paise to 89.70 against the dollar amid trade deal concerns and rising crude oil prices.
Government to release new series of retail inflation, GDP data from February, IIP from May next year
The Indian government will release new macroeconomic data series, including GDP and inflation, starting February 2026.
Granules India secures U.S. FDA tentative approval for its ADHD generic, enhancing access to critical therapy and expanding its generics portfolio.
Italy’s competition authority (AGCM) said on Monday it had fined U.S technology giant Apple and two of its divisions 98.6 million euros ($115.53 million) over alleged abuse of their dominant position in the mobile app market.
India denies duty concessions on dairy imports from New Zealand in recent trade pact negotiations, prioritizing local farmers' protection.
India-New Zealand free trade agreement offers zero-duty access, $20 billion investment pledge, and enhanced trade in multiple sectors.